Uroprase 500000IU Injection
Marketer
Chandra Bhagat Pharma Pvt Ltd
Salt Composition
Urokinase (500000IU)
Overview Uroprase 500000IU Injection
Urokinase 500,000 IU Injection dissolves dangerous blood clots obstructing blood vessels. It's indicated for patients recovering from a recent myocardial infarction, and also treats pulmonary embolism and stroke. Administration requires strict medical supervision; dosage and treatment length are determined by your physician, who will monitor your progress closely until stabilization. Potential side effects include nausea, vomiting, injection site hemorrhage, allergic responses, and hypotension. Increased bleeding risk exists. Your doctor will discuss benefits and risks before treatment. Continue all prescribed medications for ongoing health management. Caution is advised for individuals with bleeding disorders, renal or hepatic impairment; inform your doctor if pregnant, breastfeeding, or taking other medications.
Uses of Uroprase 500000IU Injection
Myocardial infarction/Pulmonary thromboembolism
Major Benefits of Uroprase 500000IU Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Uroprase 500000IU Injection:
- Allergic reaction
- Nausea
- Vomiting
- Injection site bleeding
- Decreased blood pressure
How to use Uroprase 500000IU Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Uroprase 500000IU Injection works:
Uroprase 500000IU Injection breaks down dangerous blood clots within blood vessels, re-establishing blood circulation to compromised tissue. This action averts tissue necrosis and enhances patient prognosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Uroprase 500000IU Injection may pose safety risks; seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Uroprase 500000IU is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no harm to the fetus; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Uroprase 500000IU Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingNOT RELEVANT
Uroprase 500000IU Injection is administered solely in a hospital setting.
KidneySAFE IF PRESCRIBED
Employing Uroprase 500000IU Injection in individuals with kidney impairment appears to pose minimal risk. Current evidence indicates dose modification for Uroprase 500000IU Injection might be unnecessary in such cases. However, medical advice is essential. Administration of Uroprase 500000IU Injection is contraindicated for patients exhibiting severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should use Uroprase 500000IU Injection cautiously. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Uroprase 500000IU Injection :
Should you forget a scheduled Uroprase 500000IU Injection, seek medical advice.
Facts to Know About Uroprase 500000IU Injection
| Label | Value |
|---|---|
| Chemical Type | Amino acid and peptide analogs |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Early Thrombolytic Agents |
3,018 People bought this recently